Inovio Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Inovio Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Inovio Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Inovio Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Inovio Pharmaceuticals Inc (Inovio) focuses on the development of vaccines to treat cancers and chronic infectious diseases. The company specializes in developing deoxyribonucleic acid (DNA) delivery solutions based on electroporation. Focus on R&D, lead product: INO-3107, and proprietary technologies are its strengths, even as a history of losses and dependence on major customers could be a cause for concern. Regulatory approvals, Strategic Agreements and a positive outlook of the global pharmaceutical market could provide ample growth opportunities to the company. However, intense competition, reliance on third parties, and stringent government regulations could affect the company’s business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer